Skip to main content
Premium Trial:

Request an Annual Quote

Accelerate Dx, CDC Collaborate on Early Detection of Antibiotic-Resistant Pathogens

NEW YORK (GenomeWeb News) – Accelerate Diagnostics yesterday announced that it has partnered with the US Centers for Disease Control and Prevention's Rapid Antimicrobial Susceptibility Testing Laboratory to develop faster methods of analyzing biological threats such as anthrax and plague.

Accelerate Dx will develop assays for rapid identification of infectious pathogens, their virulence markers, and their antibiotic susceptibility and resistance profiles. The CDC will provide its expertise on the molecular biology of the biothreat agents, and it will evaluate and optimize the performance of the platform using its collection of harmful biological agents.

The platform provides "high-speed identification and antibiotic susceptibility testing of pathogens," and "enables laboratories to provide critical microbiology results in hours instead of days," Tucson, Ariz.-based Accelerate Dx said in a statement. The platform uses genomic and phenotypic detection technologies and does not require samples to be grown in culture, thereby reducing the time needed to deliver results: only one hour to identify the pathogen and five hours to determine antimicrobial susceptibility.

As part of the deal, the CDC has purchased Accelerate Dx's ID/AST platform for the laboratory.

The Scan

Study Reveals New Details About Genetics of Major Cause of Female Infertility

Researchers in Nature Medicine conducted a whole-exome sequencing study of mote than a thousand patients with premature ovarian insufficiency.

Circulating Tumor DNA Shows Potential as Biomarker in Rare Childhood Cancer

A study in the Journal of Clinical Oncology has found that circulating tumor DNA levels in rhabdomyosarcoma may serve as a biomarker for prognosis.

Study Recommends Cancer Screening for Dogs Beginning Age Seven, Depending on Breed

PetDx researchers report in PLOS One that annual cancer screening for dogs should begin by age seven.

White-Tailed Deer Harbor SARS-CoV-2 Variants No Longer Infecting Humans, Study Finds

A new study in PNAS has found that white-tailed deer could act as a reservoir of SARS-CoV-2 variants no longer found among humans.